Soffer Gad
SEC insider (Form 3/4/5 filer). CIK 0001612090. Chief Business Officer at LB PHARMACEUTICALS INC (LBRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2025. Located in NEW YORK, NY.
Companies Soffer Gad has filed insider reports for
- LB PHARMACEUTICALS INC (LBRX): Officer, Chief Business Officer
Soffer Gad
CIK: 0001612090
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LB PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DispositionDirectEmployee Stock Option (Right to Buy)
26.9K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AwardDirectEmployee Stock Option (Right to Buy)
26.9K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AwardDirectEmployee Stock Option (Right to Buy)
229.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Disposition Employee Stock Option (Right to Buy) | 26,893 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award Employee Stock Option (Right to Buy) | 26,893 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award Employee Stock Option (Right to Buy) | 229,860 | - | - | Direct |
1-3 of 3 transactions